Thu 19 Nov 2026 International edition
Precision Medicine The Limits of Lifestyle Medicine: Why Standard Diabetes Prevention Fails One High-Risk Group
Medical Biotechnology Unlocking Nature’s Blueprint: Northwestern Chemists Solve a 30-Year Mystery of Rye Pollen Molecules and Their Promise for Cancer Therapy
Medical Biotechnology Unlocking the Iceman’s Microbiome: How Ötzi the Mummy Continues to Rewrite Microbiology, History, and Industrial Science
Toxicology & Pharmacology The Oral GLP-1 Frontier: Phase II Trial Shows Aleniglipron Delivers Up to 12% Weight Loss in Adults with Obesity
Toxicology & Pharmacology Decoding the Microbiome: Landmark Princeton Studies Reveal How Plant Diets and Indigestible Proteins Shape Human Health
Precision Medicine Unlocking Nutritional Dark Matter: The Hidden Chemical Universe Inside Our Food and Its Impact on Human Health
Medical Biotechnology Tracing the Tuber: How Ancient Andean Potato Farming Rewrote the Human Genome
Medical Biotechnology Deep-Sea Evolution Challenges Dogma: How Sea Anemones Defy Human Immunity Models
Oncology & Cancer Research Unlocking the Elixir: How Texas A&M Researchers Found the Cellular Key to Coffee’s Longevity Benefits
Toxicology & Pharmacology Unlocking the Brain’s Hidden Machinery: Breakthrough Yale Study Reveals How GLP-1 Medications Actually Sustain Weight Loss
Clinical Trials & Research Regulatory Roadblock: FDA Places Clinical Hold on REGENXBIO’s RGX-121 Gene Therapy for Hunter Syndrome Following Asymptomatic Spine Findings
Medical Devices & Lab Automation Bridging the Diagnostic Divide: How Dopl Technologies is Pioneering the Future of Remote Robotic Ultrasound and Telerobotic Care

Archive

Tag: alfa